Equities Mid-Day Stock Market Roundup: Wall Street Seesaws on Q1 Earnings

Equities Editors Desk |

Wall Street Stock MarketThe U.S. stock market is trading flat mostly today despite promising news from the housing sector and better-than-expected first quarter results from industry leaders like Johnson & Johnson (NYSE: JNJ). The Federal Reserve proposed new lending standards as well, which would require lenders to "make sure that prospective buyers have the ability to repay their mortgages before giving them a loan." What a novel idea. Johnson & Johnson, meanwhile, announced that revenue rose 3.5 percent, beating expectations. The company's profit dropped year-over-year, but only because of a large accounting gain from the previous year.

Major U.S. Stock Indices

DJIA: 12,220.63 (+0.16 percent)
S&P 500: 1,306.30 (+0.09 percent)
Nasdaq: 2,730.81 (-0.17 percent)
Russell 2000: 819.42 (-0.25 percent)

In other news:

  • A day after Standard & Poor's lowered its outlook on the U.S. government credit rating, Treasury secretary Timothy Geithner does some damage control. [NY Times]
  • The New York Stock Exchange (NYSE: NYX) won't shake off Nasdaq OMX (NASDAQ: NDAQ) and the InterContinental Exchange (NYSE: ICE) that easily. Nasdaq and ICE upped their offer to represent a 21 percent premium on the current NYX stock price. [Marketwatch]
  • Goldman Sachs (NYSE: GS) outperformed Wall Street expectations, but the buyout of Warren Buffett/Berkshire Hathaway's (NYSE: BRK.A) stake in the company certainly stung. [WSJ]
  • The case for raising key U.S. interest rates. Probably won't happen since the Fed still doesn't think inflation is a concern. [Fortune]

Check back as more news develops.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
GGN.P.B GAMCO Global Gold Natural Reources & Income Trust 24.59 -0.05 -0.20 5,944

Comments

Emerging Growth

CohBar Inc.

CohBar Inc is a research stage biotechnology company. The Company conducts investigational research into Mitochondrial-Derived Peptides to evaluate their therapeutic potential through in vitro and in vivo models.

Private Markets

Snapchat

Snapchat is the fastest way to share a moment with friends. The mobile app, allows users to not only share photos with friends but also control how long they can…

Uber

Uber connects riders with safe, reliable, convenient transportation providers at a variety of price-points in cities around the world. Uber makes money from charging their drivers 20% of the fare…